Cytomegalovirus in Steroid-Refractory Immune Checkpoint Inhibition-Related Colitis
J Thorac Oncol
.
2020 Jan;15(1):e15-e20.
doi: 10.1016/j.jtho.2019.07.026.
Authors
Sietze T van Turenhout
1
,
Marieke Berghuis
2
,
Petur Snaebjornsson
3
,
Sofie Wilgenhof
2
,
J A Burgers
4
,
John B A G Haanen
2
,
Jolanda M van Dieren
5
Affiliations
1
Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: sietzevanturenhout@gmail.com.
2
Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
3
Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
4
Department of Pulmonology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
5
Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
PMID:
31864555
DOI:
10.1016/j.jtho.2019.07.026
No abstract available
Publication types
Letter
MeSH terms
Colitis* / chemically induced
Colitis* / drug therapy
Cytomegalovirus
Humans
Immune Checkpoint Inhibitors
Lung Neoplasms*
Steroids / therapeutic use
Substances
Immune Checkpoint Inhibitors
Steroids